Hit Enter to search or Esc to close
0
Relugolix

Relugolix

CAS NO.:737789-87-6
MF:C29H27F2N7O5S
EINECS NO.:237-099-7
API176
Quantity
Send Inquiry
add to cart

Product Name
Relugolix
Appearance
Colourless transparent crystal powder
Specification
 99%
Test Method
HPLC
Storage
Keep in a cool, dry, dark location in a tightly sealed container or cylinder.
Shelf Time
24 months
  Solubility  DMSO:20.0(Max Conc. mg/mL);32.1(Max Conc. mM)
  Ethanol:1.0(Max Conc. mg/mL);1.6(Max Conc. mM)

Relugolix is an oral GnRH receptor antagonist for androgen deprivation therapy in the treatment of advanced prostate cancer.

Relugolix is indicated for the treatment of adult patients with advanced prostate cancer.
In a combination product with estradiol and norethindrone,
relugolix is indicated for the once-daily treatment for the management of heavy menstrual bleeding associated
with uterine fibroids in premenopausal wome.